What Happens When You Stop Wegovy or Mounjaro? (The 2026 Guide)

Introduction: The "Weight Regain" Fear

One of the most frequent questions in my clinic is: "Doctor, will I gain it all back once I stop the injection?"

It is a valid concern. We have all seen the headlines about the "Ozempic Rebound." But instead of relying on rumors, we now have definitive clinical data from the STEP 4(Wegovy) ¹ and SURMOUNT-4 (Mounjaro) ² trials that show exactly what happens to the human body when these medications are withdrawn.

Here is the science of the "Post-GLP-1" phase and how you can beat the odds.

A note on what we observe in our own clinic: the regain pattern matches the trial data closely, but with one consistent exception — patients who maintained resistance training and high protein intake throughout treatment regain noticeably less than those who did not, even when both groups stopped the medication on the same schedule. This is the variable I focus on most when planning an exit strategy with a patient.

1. The Science: The SURMOUNT-4 Results

The SURMOUNT-4 clinical trial was specifically designed to answer this question for Mounjaro (tirzepatide). ²

• The study: Patients took Mounjaro for 36 weeks and lost an average of 20.9% of their weight. Then, half the group stayed on the drug, and the other half was switched to a placebo.

• The result: Those who stayed on the drug lost an additional 5.5%. Those who stopped (the placebo group) regained 14% of their weight over the next year.

• The lesson: Weight regain is a biological reality because obesity is a chronic condition, not a temporary infection. When you stop the medication, the "biological brakes" on your hunger are released.

2. Why Does the Weight Come Back?

It isn't a lack of willpower. It is physiology. When the drug leaves your system, three things happen:

• The return of "food noise": The mental chatter about cravings and snacks that was "muted" by the drug returns, often louder than before.

• Gastric speed-up: Your stomach begins emptying at its original fast speed again, meaning you feel hungry much sooner after a meal.

• Metabolic adaptation: If you lost muscle during the treatment, your resting metabolism is now slower. If you go back to your old eating habits with a slower "engine," the fat accumulates even faster.

3. Can You Stop Successfully? (The "Exit Strategy")

The data shows that many people regain weight, but it is not a 100% guarantee. Patients who successfully maintain their weight loss usually follow these three rules:

A. The "Taper" Method (Do Not Quit Cold Turkey)

In our clinic, we do not simply stop the shots. We "taper" the dose. This might mean:

• Increasing the time between shots (e.g., every 10 days, then every 14 days).

• Lowering the dosage slowly over 3–6 months to allow your brain to adjust to the returning hunger signals.

B. The "Metabolic Engine" Protection

The patients who keep the weight off are those who prioritized muscle during the treatment. If you enter the "Post-GLP-1" phase with high muscle mass, your metabolism is strong enough to handle the return of normal hunger.

C. The Lifestyle "Hard-Coding"

You must use the 6–12 months on the drug to "hard-code" new habits. If you used the drug as a "crutch" without changing your relationship with food, the weight will return. If you used it as "training wheels" to learn portion control and high-protein eating, you have a fighting chance.

Summary Table: Stay vs. Stop

Conclusion: Is It a "Forever" Drug?

For some, obesity is a chronic metabolic disease like high blood pressure — it requires a long-term "maintenance" dose. For others, it is a tool to reach a healthy weight and reset lifestyle habits.

The most important takeaway from the studies is this: don't wait until you run out of pens to make a plan. Your "Exit Strategy" should start the same day as your first injection.

A note on uncertainty: No tapering protocol for GLP-1 medications is FDA-approved or manufacturer-endorsed. The methods described here reflect our clinical practice based on extrapolating from the SURMOUNT-4 and STEP 4 cessation data, not from a randomised trial of tapering itself. Your physician may reasonably choose a different approach.

Thinking about stopping your treatment? Don't risk a rebound. Book a "Maintenance Consultation" with Dr. Akkavich at Phuket Weight Loss Center to create a personalized tapering plan and body composition check.

References

• Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4). JAMA. 2021;325(14):1414-1425.

• Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4). JAMA. 2024;331(1):38-48.

Medically reviewed
Siam Clinic Medical Team
The medical information published on this website has been reviewed by the Siam Clinic medical team and draws on reliable medical sources, including research and peer-reviewed academic articles.

We place great importance on accuracy, clarity and appropriate presentation, so that readers can use this information to make well-informed decisions about their health.